Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Amgen is seeking a Specialist IS Business Systems Analyst to lead Configuration Management (CMDB) and IT Asset Management (ITAM) within ServiceNow. You will act as Product and Process Owner, owning governance, data quality, and ongoing optimization of ITIL-aligned processes.
You will collaborate with platform engineers, discovery owners, and business service owners to ensure accurate CMDB data, define CI relationships, and drive enhancements, audits, and reporting across the IT ecosystem.
Join Amgen’s Mission of Serving Patients. At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do. Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives. Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.
In this vital role you will collaborate with infrastructure teams, application owners, platform engineers, and service management leaders to ensure the CMDB and IT asset data is accurate, complete, and aligned to enterprise standards. A key focus will be on identifying process and data quality improvements, defining user stories, enhancing automation capabilities, and ensuring continuous alignment with compliance, audit, and operational excellence goals.
We are all different, yet we all use our unique contributions to serve patients. Amgen is seeking a Specialist IS Business Systems Analyst to serve as the Product and Process Owner for Configuration Management (CMDB) and IT Asset Management (ITAM) processes within the ServiceNow platform. This individual contributor role is responsible for the ongoing development, governance, and optimization of these ITIL-aligned processes and their supporting technologies.
As we work to develop treatments that take care of others, we also work to care for your professional and personal growth and well‑being. From our competitive benefits to our collaborative culture, we’ll support your journey every step of the way. In addition to the base salary, Amgen offers competitive and comprehensive Total Rewards Plans that are aligned with local industry standards.
Amgen is an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, disability status, or any other basis protected by applicable law. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
For more information, visit www.amgen.com and follow us on www.twitter.com/amgen